- Home
- BEEM vs BRNS Comparison
BEEM vs BRNS Comparison
Compare BEEM & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEEM | BRNS |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 30.4M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BEEM | BRNS |
|---|---|---|
| Price | $1.41 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $3.50 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.5M | 73.0K |
| Earning Date | 04-09-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $28,236,000.00 | N/A |
| Revenue This Year | $40.48 | N/A |
| Revenue Next Year | $32.17 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.97 | $0.51 |
| 52 Week High | $4.04 | $1.83 |
Technical Indicators
Market Signals| Indicator | BEEM | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 60.28 |
| Support Level | $1.38 | $0.65 |
| Resistance Level | $1.42 | $0.74 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 23.91 | 66.07 |
Price Performance
Historical ComparisonAbout BEEM Beam Global
Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.